Results 81 to 90 of about 115,882 (349)
Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study. [PDF]
PLoS ONE, 2014 The mechanisms that underlie the development and maintenance of autoimmunity in myasthenia gravis are poorly understood. In this investigation, we evaluate the role of survivin, a member of the inhibitor of apoptosis protein family, in humans and in two ...
Linda L Kusner +4 more
doaj +1 more source
GraVIS: Grouping Augmented Views from Independent Sources for Dermatology Analysis [PDF]
arXiv, 2023 Self-supervised representation learning has been extremely successful in medical image analysis, as it requires no human annotations to provide transferable representations for downstream tasks. Recent self-supervised learning methods are dominated by noise-contrastive estimation (NCE, also known as contrastive learning), which aims to learn invariant ...
arxiv
Astrophysical Constraints on Large Extra Dimensions [PDF]
Phys.Lett.B461:34-42,1999, 1999 In the Kaluza-Klein (KK) scenario with n large extra dimensions where gravity propagates in the 4+n dimensional bulk of spacetime while gauge and matter fields are confined to a four dimensional subspace, the light graviton KK modes can be produced in the Sun, red giants and supernovae. We study the energy-loss rates through photon-photon annihilation,
arxiv +1 more source
Novel Treatments in Myasthenia Gravis
Frontiers in Neurology, 2020 Myasthenia gravis (MG) is the prototypical autoimmune disorder caused by specific autoantibodies at the neuromuscular junction. Broad-based immunotherapies, such as corticosteroids, azathioprine, mycophenolate, tacrolimus, and cyclosporine, have been ...
D. Menon, C. Barnett, V. Bril
semanticscholar +1 more source
SAGE Open Medicine, 2018 Objective: The aim of this study is to determine the safety and the efficacy of amifampridine phosphate in muscle-specific kinase antibody-positive myasthenia gravis, in a 1:1 randomized, double-blind, placebo-controlled, switchback, double crossover ...
Silvia Bonanno +9 more
doaj +1 more source
Epidemiologic studies of myasthenia gravis: literature review
Нервно-мышечные болезни, 2018 The review of domestic and foreign literature devoted to epidemiological studies of myasthenia gravis has been reviewed. The article presents data on the prevalence and incidence of myasthenia gravis in several regions of Russia and abroad.
T. M. Alekseeva +3 more
doaj +1 more source
Tatalaksana terkini pada miastenia gravis
Majalah Kedokteran Andalas, 2022 Myasthenia gravis (MG) is a disorder of the neuromuscular junction that causes fluctuating muscle weakness. The etiology of this disease is due to the presence of antibodies that attack acetylcholine receptors on the postsynaptic membrane (autoimmune ...
Lydia Susanti
doaj +1 more source
Tolosa-Hunt syndrome with general myasthenia gravis involvement [PDF]
Journal of Integrative Neuroscience, 2020 Tolosa-Hunt syndrome is an uncommon disease that exhibits unilateral periorbital pain or headache, accompanied by cranial nerve palsies. Myasthenia gravis is an acquired immune system disease involving the neuromuscular junction.
Lu Li, Zhe Wang, Ming-Ou Lu
doaj +1 more source
Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis
Frontiers in Immunology, 2020 Myasthenia gravis is an autoimmune disease in which immunoglobulin G (IgG) autoantibodies are formed against the nicotinic acetylcholine receptor (AChR) or other components of the neuromuscular junction.
K. Gable, J. Guptill
semanticscholar +1 more source